Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Placebo- and Active-controlled, 4-period, Crossover Study to Investigate Effects of Elinzanetant on Simulated Driving Performance and Cognitive Function in Healthy Women

Next Previous
Search
Trial Profile

A Randomized, Double-blind, Placebo- and Active-controlled, 4-period, Crossover Study to Investigate Effects of Elinzanetant on Simulated Driving Performance and Cognitive Function in Healthy Women

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Elinzanetant (Primary) ; Zopiclone (Primary)
  • Indications Hot flashes; Vasomotor symptoms
  • Focus Adverse reactions
  • Sponsors Bayer

    • Most Recent Events

    • 04 Sep 2024 According to a Bayer media release, data assessing the effects of elinzanetant on simulated driving performance in healthy women from this study will be presented by Senka Djordjevic at annual meeting of The Menopause Society (TMS) which takes place on 12th September 2024, in Chicago, IL, United States.
    • 07 May 2024 Status changed from active, no longer recruiting to completed.
    • 29 Feb 2024 Planned End Date changed from 16 Apr 2024 to 10 Apr 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top